Archives — Current Month (7)

Gold at Year-End and a Lesson in Shorting (10/17/2017)

Ron Struthers of Struthers' Resource Stock Report provides his outlook gold stock performance going into the end of the year, offers a lesson in Shorting 101, and discusses his views on particular companies.

more>

Reliq Health Technologies Quickly Gaining Traction in Fast Growing Telemedicine Market (10/11/2017)

The rapid increase in the incidence of chronic diseases and the need to reduce healthcare costs have led to the growth in telemedicine, and Reliq Health Technologies is adding thousands of patients to its rolls.

more>

Cannabis Company Forms Partnership to Develop Pharmaceuticals (10/06/2017)

Analyst Russell Stanley with Echelon Wealth Partners explained the significance of the recent licensing agreement signed by this Canadian medical marijuana producer and distributor.

more>

Telemedicine Platform Is Quickly Gaining Traction in Fast Growing Market (10/05/2017)

The rapid increase in the incidence of chronic diseases and the need to reduce healthcare costs have led to the growth in telemedicine, which has companies racing to bring new products to market.

more>

Reliq Health Technologies Quickly Gaining Traction in Rapidly Growing Telemedicine Market (10/05/2017)

The rapid increase in the incidence of chronic diseases and the need to reduce healthcare costs have led to the growth in telemedicine, which has companies racing to bring new products to market.

more>

Japan Is Fertile Ground for Biotech Deals (10/04/2017)

Japan and the United States are hotspots for companies that are looking to license-out exciting regenerative medicine technology, says Colin Lee Novick, managing director of CJ PARTNERS. In this interview with The Life Sciences Report, Novick discusses a regenerative medicine company pursuing partnerships in Japan for its cell therapies to treat chronic tendinosis, damaged or aged skin, and pattern baldness.

more>

Small Biotech Enters Patent Deal with British Company Targeting Schizophrenia (10/04/2017)

A small-cap American biotech has secured a patent agreement with a larger British firm, garnering the attention of three sector analysts.

more>

More Archives

2017Sep Aug Jul Jun May Apr Mar Feb Jan

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2014Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2013Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2012Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Life Sciences Report Newsletter Free

A valid email address is required to subscribe